Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Netflix fell 11% after Q3 revenue guidance of $9.73 billion missed the $9.83 billion consensus, offsetting a Q2 beat on earnings and subscriber additions.
Michael Burry said Hong Kong stocks are undervalued while global peers ride the AI rally. The investor urged a hunt for bargains, with JD.com among the names in focus.
AMR Resources Acquisition raised $250M in its Nasdaq IPO, pricing 25M units at $10 each. The SPAC targets energy and natural resources deals in North America.
Nasdaq IPO volume in 2026 is on track to break the all-time record, driven by a surge in tech listings in recent months. The pace of capital raised suggests the market is absorbing supply without disruption.
IT stocks rallied 2-3% as the rupee slipped past 83.50 and deal optimism returned. Infosys, Wipro, and HDFC Bank led gains. Alpha Score data shows Infosys at 57, Wipro at 46, HDFC Bank at 44.
DXP Enterprises' acquisition of General Repair Services continues its roll-up strategy. Analysts say the model could support a higher multiple. The next earnings report will offer more detail.
Array Technologies pays up to $203M for a solar wire management firm, adding balance-of-system products. Weak Alpha Score 23. (ARRY)
The Invesco QQQJ ETF holds NASDAQ's 101st-200th stocks, but its best performers regularly get promoted to QQQ. The structural drag has left it trailing the larger fund, a Seeking Alpha analyst argues.
REGENXBIO plans a $100M stock offering with a 15% overallotment option after shares fell 60% in the past year. The gene-therapy company had $359M in cash at end of June.
Fort Technology (FRTT) replaced its audit committee chair and added a new director as Tamir Fayerman resigned. The pest-control company's subsidiary has nearly 20 years of technical experience.
Cosmos Health repurchased 250k more shares at $0.28, bringing total buyback to $1.04M. CEO says shares trade below value. Program expires Dec. 31.
Goldman Sachs downgraded AEP to neutral after the stock's 28% run already prices in data-center load growth and a favorable Ohio ruling, analysts said.
Piper Sandler starts AST SpaceMobile at Overweight on valuation and earnings path. SpaceX and Rocket Lab get Neutral ratings.
Vericel will report second-quarter 2026 results on July 30. The call will cover MACI, Epicel, and NexoBrid performance. Replay available through July 2027.
Bel Fuse will report Q2 2026 results after the July 29 close, with a conference call at 4:30 p.m. ET covering the period ended June 27.
Breadth narrows. Megacap gains mask broad selling. Traders see risk of reversal. May PCE data due Friday is next test. S&P 500 equal-weight lag widens.
A Seeking Alpha analyst who called National Beverage a sell before the pandemic notes its 90% total return trailed the broader market, and holds no position.
IT stocks lift Nifty 0.28% as HCL Tech hits 52-week high. Q1 earnings season in focus with financials and autos expected to lead. FIIs sold ₹736 crore, DIIs bought ₹705 crore.
CEO Tom McClelland set a $150M revenue target and 50% gross margin goal by fiscal 2029, backed by a record $111M funded backlog. Shares rose 4.2% after-hours.
Trump says NY's one-year data center pause will cost jobs and tax revenue as AI fuels demand. NVDA, a key chipmaker, rose 0.33% with an Alpha Score of 74.
Oakmark Select Fund trailed the S&P 500 in Q2 as AI-led narrowness punished value strategies. Health care and staples helped; tech and energy hurt.
Guggenheim upgrades Nextpower to Buy, calling the 33% drop from May peak overdone. Alpha Score 49/100 reflects mixed signals. Target implies 40% upside.
Financials have been overbought for 22 straight sessions, the longest stretch in two years. The sector is outpacing the S&P 500 by 4 percentage points, driven by bank earnings and yield-curve steepening.
Shares fell 2% Wednesday, closing about 34% below the $135 IPO price set last month. The stock had surged to $202 in its first month of trading.
Aehr Test Systems guided FY27 revenue $130M-$150M, citing record backlog and AI/photonics demand. The company also discussed margin outlook and risks.
Lucid denies bankruptcy rumors but shares fall 7% as margin calls cascade. With $3.4B liquidity and Alpha Score 23, the stock remains vulnerable.
Caplin Point Labs at ₹2,658 offers a buy with a stop at ₹2,480 and a trailing stop at ₹2,695. Oil surged on Gulf hostilities. Gold edged up. China data beat.
Fastenal missed Q2 revenue estimates at $1.92B, but EPS of $0.52 beat by a penny. Margins held steady as vending and on-site sales hit 42% of revenue. The Alpha Score is 51/100, Mixed.
Lynk Pharmaceuticals finished patient enrollment in a Phase III trial of its oral JAK1 inhibitor zemprocitinib for active ankylosing spondylitis.
KMTS reports Q4 revenue $35.4M (+66%), gross margin 68.5%. Guides FY2027 to $137M, expects 70%+ margins. Shares up 8% after-hours.